Optimizing Insulin Absorption and Insulin Injection Technique in Older Adults
NCT01213901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-01-18
Summary
To determine which anatomic site offers the most consistent (superior) absorption of insulin.
To determine the injection technique which allows the most consistent subcutaneous injection of insulin (to pinch or to spread).
Hypothesis:
Based on age-related changes in the amount of subcutaneous fat we anticipate that the absorption of insulin from various anatomical sites will differ.
Justification:
To date health care professionals have extrapolated data obtained from younger adults and applied the results to the elderly.
Objectives:
To determine the rate of insulin absorption from different anatomic sites in diabetic patients over the age of 70.
To determine the best practice for subcutaneous injection in older adults.
Research Method:
Measurement of serial glucose and insulin levels using 360 minute euglycemic clamp studies.
Statistical Analysis:
Paired t test, repeated measures ANOVA
Conditions
Interventions
- PROCEDURE
-
Lispro insulin
Each patient will receive 2 insulin injections in the abdomen: Once using a pinch method and once using a spread method.
Sponsors & Collaborators
-
University of British Columbia
lead OTHER
Principal Investigators
-
Gale Tedder · Vancouver Coastal Health Research Institute
-
Chris Lockhart · Vancouver Coastal Health Research Institute
-
Lee Ann Trimble · Vancouver Coastal Health Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2012-07-31
- Completion
- 2014-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes
NCT04739241 ·Status: COMPLETED ·Phase: PHASE4
-
CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional Study
NCT02258945 ·Status: COMPLETED
-
Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the InsuPatch Device During Daily Life
NCT01114061 ·Status: SUSPENDED ·Phase: NA
-
Arterial Puncture Using Insulin Syringe is Less Painful Than Standard Syringe
NCT01996189 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously
NCT01061216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Insulin Management for Exercise in Patients With Type 1 Diabetes
NCT03130101 ·Status: COMPLETED ·Phase: NA
-
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
NCT02914730 ·Status: COMPLETED
-
Diabetes in the Elderly: Prospective Study
NCT01131052 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
NCT00553488 ·Status: COMPLETED ·Phase: PHASE2
-
Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes
NCT02910141 ·Status: COMPLETED
-
Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy
NCT01574508 ·Status: UNKNOWN ·Phase: PHASE4
-
Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion
NCT01557907 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control
NCT02517242 ·Status: UNKNOWN ·Phase: PHASE4
-
Post-exercise Insulin Reductions in Type 1 Diabetes
NCT01531855 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Adipose Tissue of Diabetic Patients
NCT00813410 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle
NCT00602914 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH
NCT06074965 ·Status: COMPLETED ·Phase: NA
-
Intra-Arterial Microdosing: Proof-of-Concept in Humans
NCT02304211 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hyaluronidase Effect on Infusion Set Life
NCT02199028 ·Status: COMPLETED ·Phase: PHASE1
-
Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered
NCT03838783 ·Status: UNKNOWN ·Phase: PHASE4
-
OP5-005 Using Omnipod 5 in Adults With Type 2
NCT05815342 ·Status: COMPLETED ·Phase: NA
-
Prevention of Severe Hypoglycemia in Type 1 Diabetes
NCT00360984 ·Status: COMPLETED ·Phase: PHASE4
-
Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes
NCT01713348 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
NCT03433677 ·Status: COMPLETED ·Phase: PHASE3
-
Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus
NCT01621308 ·Status: COMPLETED